Amoéba is a disruptive biotech company that develops and produces a biological biocide for industrial water systems as an alternative to chemicals.

Amoéba is also working on a new application to use Willaertia Magna C2c Maky microorganism as a biocontrol agent for the prevention of plan diseases. It has recently announced promising results of in vitro trials conducted with Willaertia Magna C2c Maky microorganism.

The company is based in Chassieu (Lyon, France).

Contact Info: